← Back to headlines
Pfizer to Seek FDA Approval for Lyme Disease Vaccine Candidate
Pfizer and French partner Valneva are moving forward with plans to seek regulatory approval for their Lyme disease vaccine candidate, following successful phase 3 trial results. The companies are now seeking FDA approval for the vaccine.
23 Mar, 11:51 — 23 Mar, 13:36
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
cnbc
Center
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
cnbcMostly Factual12m ago
Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss
Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle weakness and pain.
Read full article →seeking-alphaMixed1h ago
Pfizer, Valneva SE report phase 3 results for Lyme vaccine candidate
Read full article →Coverage Timeline
First report: seeking-alpha · 23 Mar, 11:51|Full coverage: 2 · 2h|Window: 2h
